Company: JUNS
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001493152-25-023603
Chunk: 120

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-14
Form: 10-Q
Item: Item 1
Chunk 120
---
 
     (1,632,926)

    Other
    Income (Expenses): 

    Interest
    income 
     10,212  
     23  
     33,627  
     138 
  
    Gain
    (loss) on change in fair value of derivative liability 
     -  
     9,885  
     -  
     (53,257)
  
    Interest
    expense 
     (1,193) 
     (107,382) 
     (3,557) 
     (217,821)
  
    Gain
    on extinguishment of debt 
     -  
     -  
     -  
     951,868 
  
    Other
    income 
     -  
     -  
     -  
     40,000 
  
    Total
    other income (expenses), net 
     9,019  
     (97,474) 
     30,070  
     720,928 

    Net
    (loss) income 
    $(2,288,034) 
    $(591,021) 
    $(6,069,866) 
    $(911,998)

    Net
    (loss) income per common share: 

    Basic and Diluted 
    $(0.07) 
    $(0.02) 
    $(0.18) 
    $(0.03)

    Weighted
    average number of common stock outstanding: 

    Basic and Diluted 
     34,039,906  
     31,065,688  
     33,445,006  
     27,829,820 

The
accompanying notes are an integral part of these condensed consolidated financial statements

5

JUPITER
NEUROSCIENCES, INC.

CONDENSED
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)

FOR
THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2025 AND 2024

(Unaudited)

For
the Three Months Ended September 30, 2025

    Shares  
    Amount  
    Capital  
    Deficit  
    (Deficit) 

    Common Stock  
    Additional
                                                                                Paid in  
    Accum